Ma Private Wealth Abb Vie Inc. Transaction History

Ma Private Wealth

$533 Million
Q3 2024

A detailed history of Ma Private Wealth transactions in Abb Vie Inc. stock. As of the latest transaction made, Ma Private Wealth holds 2,246 shares of ABBV stock, worth $382,606. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,246

Previous 2,045 9.83%

Holding current value

$382,606

Previous $350,000 26.57%

% of portfolio

0.08%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $32,931 - $40,065	201 Added 9.83%	2,246 $443,000
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $95,572 - $108,895	-598 Reduced 22.63%	2,045 $372,000
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $103,888 - $117,002	-755 Reduced 22.22%	2,643 $409,000
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $133 - $154	-1 Reduced 0.03%	3,398 $506,000
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $132 - $164	-1 Reduced 0.03%	3,399 $457,000
Q2 2022 Jul 14, 2022	SELL	$137.62 - $174.96 $5,229 - $6,648	-38 Reduced 1.11%	3,400 $517,000
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $1,319 - $1,637	10 Added 0.29%	3,438 $557,000
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $3,222 - $4,077	30 Added 0.88%	3,428 $464,000
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $3,298 - $3,744	31 Added 0.92%	3,398 $367,000
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $3,156 - $3,516	30 Added 0.9%	3,367 $379,000
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $3,375 - $3,716	33 Added 1.0%	3,337 $361,000
Q4 2020 Jan 11, 2021	SELL	$80.49 - $108.67 $13,602 - $18,365	-169 Reduced 4.87%	3,304 $354,000
Q3 2020 Oct 26, 2020	BUY	$85.91 - $100.83 $2,749 - $3,226	32 Added 0.93%	3,473 $304,000
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $2,494 - $3,338	34 Added 1.0%	3,441 $338,000
Q1 2020 Apr 16, 2020	SELL	$64.5 - $97.79 $2,064 - $3,129	-32 Reduced 0.93%	3,407 $260,000
Q4 2019 Jan 27, 2020	SELL	$72.13 - $90.25 $20,412 - $25,540	-283 Reduced 7.6%	3,439 $304,000
Q3 2019 Oct 10, 2019	SELL	$62.98 - $75.72 $112,041 - $134,705	-1,779 Reduced 32.34%	3,722 $282,000
Q2 2019 Jul 17, 2019	SELL	$65.7 - $83.98 $8,475 - $10,833	-129 Reduced 2.29%	5,501 $400,000
Q1 2019 Apr 24, 2019	SELL	$77.14 - $90.79 $53,920 - $63,462	-699 Reduced 11.04%	5,630 $454,000
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $492,712 - $607,647	6,329 New	6,329 $583,000

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ma Private Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Ma Private Wealth with notifications on news.

Account

Ma Private Wealth Abb Vie Inc. Transaction History